Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities
Net loss	$ (10,278)	$ (48,217)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	17,527	17,728
Amortization of operating lease right-of-use assets and intangible assets	553	749
Non-cash interest expense	814	0
Stock-based compensation	301	542
Loss (gain) on disposal on property, plant, and equipment	44	(87)
Gain from forgiveness of accounts payable and deposits, net	0	(518)
HSL s.l.r. settlement adjustment	(295)	0
Gain on foreign exchange	0	(2,105)
Change in fair value of notes payable, warrant liabilities, and derivative call options	(51,458)	(27,885)
Change in fair value of related party notes payable and related party warrant liabilities	277	7
Changes in operating assets and liabilities:
Accounts receivables	(664)	0
Deposits	(2,823)	5,955
Inventory	362	4,804
Other current and non-current assets	2,515	(1,808)
Accounts payable	(651)	3,559
Financial obligations on lease back transaction	0	751
Operating lease liabilities	(703)	(755)
Net cash used in operating activities	(20,295)	(14,719)
Cash flows from investing activities
Proceeds from the sale of equipment	0	87
Payments for property and equipment	(1,568)	(99)
Net cash used in investing activities	(1,568)	(12)
Cash flows from financing activities
Proceeds from other financial obligations	1,133	0
Payments of notes payable and other financing obligations	(309)	0
Payments of notes payable issuance costs	(99)	(25)
Net cash provided by financing activities	24,601	12,013
Effect of exchange rate changes on cash and restricted cash	(419)	(2)
Net (decrease) increase in cash and restricted cash	2,319	(2,720)
Cash and restricted cash, beginning of period	7,174	4,025
Cash and restricted cash, end of period	9,493	1,305
Cash and restricted cash
Cash	9,458	407
Restricted cash	35	898
Cash, cash equivalents, restricted cash, and restricted cash equivalents	9,493	1,305
Supplemental disclosure of cash flow information
Cash paid for interest	1,376	465
Cash paid for taxes	0	0
Supplemental disclosure of noncash investing and financing activities
Additions of property and equipment included in accounts payable and accrued expenses	0	45,424
Settlement of HSL s.l.r. liability in Class A Common Stock	1,185	0
Conversion of notes payable, related party notes payable and accrued interest into Class A Common Stock	15,573	9,118
Issuance of warrants with the SPA Portfolio Notes	15,084	1
Nonrelated Party
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on settlement of notes payable	15,920	11,403
Changes in operating assets and liabilities:
Accrued expenses and other current and non-current liabilities	6,945	1,749
Accrued interest expense	0	5,114
Cash flows from financing activities
Proceeds from notes payable, net of original issuance discount	22,000	9,038
Related Party
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on settlement of notes payable	1,180	14,295
Changes in operating assets and liabilities:
Accrued expenses and other current and non-current liabilities	139	0
Cash flows from financing activities
Proceeds from notes payable, net of original issuance discount	$ 1,876	$ 3,000